BRAF and malignant colon neoplasm: On the other hand, although CTHRC1 was positively correlated with the BRAF(V600E) mutation in melanoma, CTHRC1 expression levels were positively associated with the OS rate in melanoma patients, which was the opposite with colon cancer and thyroid cancer.